MentiNova

    OverviewSuggest Edit

    MentiNova develops an oral medication to help treat symptoms of Parkinson’s disease. Its primary strategy is to use a drug that is currently clinically approved for another indication and repurpose it for the treatment of L-Dopa Induced Dyskinesia in patients with Parkinson’s disease.
    TypePrivate
    Founded1995
    HQPrinceton, US
    Websitementinova.com

    Locations

    MentiNova is headquartered in
    Princeton, United States

    Location Map

    Latest Updates

    Employees (est.) (Mar 2020)2

    MentiNova Office Locations

    MentiNova has an office in Princeton
    Princeton, US (HQ)
    155 Village Blvd, 155 Village Blvd #130
    Show all (1)

    MentiNova Financials and Metrics

    Summary Metrics

    Founding Date

    1995
    Show all financial metrics

    MentiNova Online and Social Media Presence

    Embed Graph

    MentiNova Frequently Asked Questions

    • When was MentiNova founded?

      MentiNova was founded in 1995.

    • How many employees does MentiNova have?

      MentiNova has 2 employees.

    • Who are MentiNova competitors?

      Competitors of MentiNova include Horizon Therapeutics, Esperion Therapeutics and Amphastar Pharmaceuticals.

    • Where is MentiNova headquarters?

      MentiNova headquarters is located at 155 Village Blvd, 155 Village Blvd #130, Princeton.

    • Where are MentiNova offices?

      MentiNova has an office in Princeton.

    • How many offices does MentiNova have?

      MentiNova has 1 office.